Among the companies with shares expected to trade actively in
Monday's session are Forest Laboratories Inc. (FRX), Navistar
International Corp. (NAV) and Centene Corp. (CNC).
Forest Laboratories lowered its fiscal year 2013 earnings
guidance, saying the March patent exclusivity expiration on its
depression treatment Lexapro turned out to hit the company harder
than expected. Initial prices from authorized generic distributor
Teva Pharmaceutical Industries Ltd. (TEVA) have been much lower
than Forest Labs anticipated, cutting royalty income, the company
said. Shares of Forest Labs dropped 5% to $33.90 premarket.
Activist investor Carl Icahn raised his stake in Navistar
International, signaling his renewed interest in the commercial
truck and engine maker as it attempts to recover from two straight
quarterly losses with a revamped management team. Shares of
Navistar climbed 5.8% to $30 in recent premarket trade.
Centene cut its full-year earnings guidance as the Medicaid
insurer saw higher-than-expected medical costs in Kentucky and
Texas, as well as in its Celtic business, and is bracing for an
additional potential writedown. Shares of the operator of Medicaid
and specialty-based programs tumbled 24% to $27 premarket.
Diamond Foods Inc.'s (DMND) shares fell 3.4% to $19.48 premarket
as the beleaguered snack maker said it won't meet today's Nasdaq
deadline to file delayed quarterly reports. As such, it expects to
get a delisting warning, which the company would appeal in order to
delay any potential pulling of its stock from the exchange. It will
also seek an extension for holding its annual meeting, which it
doesn't expect to happen before July 31.
Shares of Ampio Pharmaceuticals Inc. (AMPE) rose 9.4% to $3.50
premarket after the company announced positive results from a trial
of its treatment of retina swelling related to diabetes.
EnergySolutions Inc. (ES) shares declined 13% to $3.11 premarket
as the nuclear industry service provider appointed board member
David Lockwood as its new chief executive, and lowered its
full-year adjusted earnings estimate.
IntegraMed America Inc. (INMD) has agreed to go private in a
cash deal that values the health-care management company at around
$169.5 million. The company's agreement with Sagard Capital
Partners L.P. offers shareholders $14.05 a share, a premium of
roughly 24% to its Friday closing price. Shares jumped nearly 20%
to $13.59 in premarket trading.
Mercury Computer Systems Inc. (MRCY) agreed to acquire
Micronetics Inc. (NOIZ), a maker of radio and microwave frequency
subsystems and components, in a roughly $67.7 million cash deal as
it looks to bolster its sensor processing chain. Micronetics
shareholders will receive $14.80 a share, nearly double the price
of its Friday close. Shares of Micronetics jumped 95% to $14.57
premarket.
Watchlist:
Healthways Inc. (HWAY) lowered its full-year earnings guidance
to reflect increased interest expense from refinancing its lines of
credit.
Johnson & Johnson (JNJ) said it plans to record a special
charge of roughly $600 million in its second quarter to increase
its accrual for potential legal settlements, as it has faced a
series of lawsuits over accusations of bribery and improper
drug-marketing practices.
LHC Group (LHCG) decided to remain independent, ending a
strategic review that the home-health and hospice-services provider
began late last year.
Shutterfly Inc. (SFLY) said its chief technology officer, Neil
M. Day, Jr., will resign to spend time with his family.
WebMD Health Corp. (WBMD) said it will appoint a nominee of
activist investor and largest shareholder Carl Icahn to its board,
expanding its size by one seat.
-Write to Corrie Driebusch at corrie.driebusch@dowjones.com